Vericel (NASDAQ:VCEL) Given “Overweight” Rating at Stephens
Stephens reaffirmed their overweight rating on shares of Vericel (NASDAQ:VCEL – Free Report) in a research report sent to investors on Monday,Benzinga reports. They currently have a $67.00 target price on the biotechnology company’s stock. Several other analysts also recently weighed in on VCEL. Wall Street Zen downgraded Vericel from a “hold” rating to a […]
More Stories
Putin Praises Trump’s Ukraine Peace Push, Suggests US–Russia Nuclear Arms Deal
By Tom Ozimek Russian President Vladimir Putin on Thursday praised the Trump administration’s “energetic and sincere” efforts to end the...
New York Manufacturing Employment Down 45 Percent Since 2000: Analysis
By Andrew Moran Manufacturing employment levels in New York State have declined by 45 percent since 2000, a new analysis...
Blue Barn Wealth LLC Has $384,000 Position in Alphabet Inc. (NASDAQ:GOOGL)
Blue Barn Wealth LLC lowered its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 8.3% in the 1st quarter,...
Gemini Chatbot Got a New Update: Enhanced Memory with New Privacy Options
Google is coming up with new updates to its Gemini AI assistant that aim to make conversations more personal and...
PNC Financial Services Group Inc. Has $472,000 Stock Position in CAVA Group, Inc. (NYSE:CAVA)
PNC Financial Services Group Inc. raised its position in CAVA Group, Inc. (NYSE:CAVA – Free Report) by 123.4% during the...
Alphabet Inc. (NASDAQ:GOOGL) Shares Sold by VeraBank N.A.
VeraBank N.A. decreased its holdings in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 0.8% during the 1st quarter,...